Pacific Edge Appoints Vice President of Market Access

Pacific Edge today announces the appointment of David Sosa into the new role of Vice President of Market Access and Reimbursement for Pacific Edge Diagnostics USA (PEDUSA). 

Mr Sosa’s appointment further strengthens the PEDUSA executive suite as it seeks to accelerate the adoption of its advanced genomic biomarker Cxbladder tests as the standard of care for the suspicion of urothelial cancer in patients presenting with haematuria and in the surveillance for disease recurrence.

Mr Sosa, who joined Pacific Edge on June 27, will play a critical role in ensuring the optimal systems and processes are in place to facilitate insurance coverage, payment, test reimbursement, patient access and seamless engagement with all stakeholders in the healthcare value chain. He will have responsibility for medical policy and contracting efforts with healthcare payors to drive commercial success and operating efficiency as well as play a key role in piloting commercial strategies in the Americas.

He brings to Pacific Edge more than 25 years’ experience working with pharmaceutical companies in the US, including most recently Decipher Biosciences, which provides urologic cancer tests, and MDxHealth, which provides tests for the early detection of clinically significant prostate cancer. 

Pacific Edge Chief Executive Dr Peter Meintjes, said: “We are delighted to welcome David to Pacific Edge at this inflection point for our growth. Cxbladder adoption has been steadily increasing since its CMS coverage in 2020 and it is crucial we have the right policies and processes to deliver the best experience for clinicians, payers and patients as they engage with Pacific Edge. David’s extensive experience in urology diagnostics will provide valuable expertise as we expand our market access and reimbursement activities within and beyond the USA.” 

Executive Chairman of PEDUSA David Levison said: “I’m excited about this new role and the value it will add to our growing business in the United States. In addition to bolstering the PEDUSA executive team’s skills and experience, David will lead a number of activities that are new for the company as we explore additional opportunities in the region."

Mr Sosa graduated from Rutgers University in New Jersey with a Bachelor of Science degree in Environmental Science and Resource Engineering. He also holds an MBA in Information Systems from Florida International University’s College of Business, and a Master of Science in Finance from Florida International University.

At Decipher Biosciences he was Director, Managed Care, Government, Medicaid and International Reimbursement. At MDxHealth he was Business Director, Managed Care and International Access. Prior to this he was National Accounts Manager at Prometheus Laboratories, a Nestlé Health Science Company.

Mr Sosa said: “I am excited by Pacific Edge’s recent achievements and its potential for growth, particularly in the United States. I’m impressed by the strong team in place and the diverse and deep expertise across the company. Pacific Edge’s innovations, including its bladder cancer diagnostic technology Cxbladder, are groundbreaking and I’m looking forward to supporting the company’s growth and success.”